Latest Manufacturing News

Tungsten Mining NL’s Pre-Feasibility Study confirms Mt Mulgine as a world-scale tungsten project, targeting first production in mid-2029 with robust economics and low operating costs.

Arovella Therapeutics has released the first clinical batch of its off-the-shelf cell therapy ALA-101 and activated its inaugural trial site at The Alfred, setting the stage for patient dosing later this month.

Boresight Ltd’s US subsidiary has landed a US$383,275 purchase order from a repeat North American military customer, tripling previous drone orders and expanding its footprint in counter-drone training.

Iondrive Limited’s updated evaluation of its IONSolv™ technology projects a US$243 million post-tax NPV and US$62 million annual EBITDA for a single rare earth recovery module in the US, driven by high feedstock grade assumptions and independently validated recoveries.

Phoslock Environmental Technologies has advanced a new range of lanthanum-enhanced phosphorus-binding products showing up to four times the capacity of current offerings, with pilot and manufacturing tests confirming strong performance and low lanthanum release. Field trials are underway, aiming for commercial sales in 2027.

Lithium Universe’s Pre-Feasibility Study for its Brownsville Lithium Carbonate Refinery reveals robust economics and strategic US positioning, aiming to close North America’s lithium conversion gap.

Bayan Mining's patented ion-exchange technology demonstrated a 14-fold increase in yttrium concentration and a two-fold purity upgrade in independent bench-scale trials at the University of Queensland, highlighting commercial potential amid global supply disruptions.

Viridis Mining has placed its first major equipment order for the Colossus Rare Earth Project, securing critical-path pressure filtration technology that underpins its 2028 production target.

The ACCC has approved Peter Warren Automotive's acquisition of Wakeling Automotive's dealerships in Sydney's Macarthur region, conditional on divesting eight sites to preserve competition.

Ionic Rare Earths (ASX: IXR) and US Strategic Metals have agreed to a 50-50 joint venture to develop rare earth magnet recycling facilities at a fully permitted Missouri site, backed by US$100 million in funding.

Cleo Diagnostics has received its first commercial batch of ovarian cancer test kits from Bio-Techne, marking the start of analytical validation critical for its FDA submission planned in early 2027.

Imricor Medical Systems has reached a crucial milestone as the FDA accepts and closes the manufacturing module of its Premarket Approval submission, advancing its MR-guided electrophysiology devices closer to US market entry.